Nur77/NR4A1

Nur77/NR4A1 is an orphan nuclear receptor and immediate-early response transcription factor within the NR4A family that rapidly integrates stress, inflammatory, metabolic, and growth-factor signals into transcriptional programs regulating cellular homeostasis, differentiation, apoptosis, and immune responses^[1][2]. Mechanistically, NR4A1 functions through genomic and non-genomic activities; it acts as a nuclear transcription factor by binding NR4A response elements, while stimulus-dependent translocation from the nucleus to mitochondria can trigger apoptotic signaling pathways, highlighting its context-dependent regulatory capacity^[2][3][4]. In disease-related settings, NR4A1 participates in inflammation, metabolic regulation, fibrosis, immune-cell function, and multiple cancer models, where it influences cell proliferation, survival, apoptosis, and metabolic reprogramming through pathways linked to glycolysis, mTOR signaling, and cellular stress responses^[1][5][6]. Compared with the closely related NR4A family members NR4A2 (Nurr1) and NR4A3 (NOR-1), NR4A1 shares conserved DNA-binding properties but exhibits distinct transcriptional regulation and biological functions determined by differences in its N-terminal regulatory region and cellular context^[4][7]. For experimental applications, NR4A1 has attracted considerable interest as a druggable nuclear receptor because several direct-binding ligands have been identified; the natural product cytosporone B functions as an NR4A1 agonist that promotes receptor transactivation and can induce mitochondrial translocation, whereas structurally distinct antagonists have been used to suppress NR4A1-dependent oncogenic pathways in cancer models^[3][8].